Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2018-05-03 AGM Information
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Beslut vid årsstämma i Medivir den 3 maj 2018
AGM Information Classification · 99% confidence The document is titled "Beslut vid årsstämma i Medivir den 3 maj 2018" (Decisions at the Annual General Meeting in Medivir on May 3, 2018). It details resolutions passed regarding the approval of financial statements, remuneration, election of the board and auditor, approval of compensation guidelines, and authorizations for share issues (including deviation from pre-emptive rights and with pre-emptive rights) and option issuance. These topics are the core content of an Annual General Meeting (AGM) or the official minutes/summary thereof. Since the document explicitly details the decisions made at the AGM, the most appropriate classification is AGM Information (AGM-R).
2018-05-03 Swedish
Number of shares and votes in Medivir
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a change in the number of shares and votes due to the conversion of class A shares to class B shares. This directly relates to a change in the company's capital structure or share count. This aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA), which covers changes in capital structure, including share counts.
2018-04-30 English
Antal aktier och röster i Medivir
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document announces a change in the total number of shares and votes due to the conversion of all A-shares to B-shares. It specifies the exact number of shares and votes as of the last trading day of the month (April 30, 2018). This type of announcement, dealing with changes in the capital structure (share classes and total count), aligns best with the 'Share Issue/Capital Change' category (SHA). It is not a general regulatory filing (RNS) because it addresses a specific capital structure event, nor is it a financing update (CAP) which usually implies raising new capital through issuance or debt. The document is short and directly reports the change, making SHA the most precise fit.
2018-04-30 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'MEDIVIR AB – DELÅRSRAPPORT JANUARI – MARS 2018' (Interim Report January – March 2018). It contains comprehensive financial statements, management commentary, operational updates, and research and development progress for the first quarter of 2018. It is a substantive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-04-27 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY – MARCH 2018' and contains comprehensive financial statements, including income statements, cash flow summaries, and detailed management analysis of business performance for the specified quarter. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. Q1 2018
2018-04-27 English
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for an individual ('Nils Gunnar Johansson') in Medivir Aktiebolag. It explicitly shows the 'Before the transaction' and 'After the transaction' holdings, including the number of shares and voting rights percentage. The section 'Reason for major shareholding notification' confirms the nature of the filing. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing type code MRQ.
2018-04-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.